Related Experiment Video
Updated: Jan 12, 2026

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.7K
Alzheimer's disease classification based on multimodal consistent distribution and trusted fusion
Xiaoyan Kui1, Yulan Dai1, Beiji Zou1
1School of Computer Science and Engineering, Central South University, Changsha, China.
Summary
This study introduces a new method for Alzheimer's disease (AD) classification using multimodal data. It effectively handles data differences and reliability issues for more accurate AD diagnosis.
Area of Science:
- Neuroimaging
- Biostatistics
- Machine Learning
Background:
- Alzheimer's disease (AD) classification benefits from multimodal data fusion, integrating sources like MRI, PET, and cognitive scores.
- Existing fusion methods struggle with data heterogeneity and varying reliability across different modalities, hindering diagnostic accuracy.
- Robust AD classification requires addressing these challenges to improve diagnostic performance.
Purpose of the Study:
- To develop a novel Alzheimer's disease classification framework using multimodal consistent distribution and trusted fusion.
- To effectively integrate structural magnetic resonance imaging (sMRI), positron emission tomography (PET), and mini-mental state examination (MMSE) data.
- To enhance the reliability and accuracy of AD classification by managing data heterogeneity and uncertainty.
Main Methods:
- Projecting sMRI, PET, and MMSE data into a unified latent feature space for consistent distribution alignment.
- Employing a Dirichlet distribution-based mechanism to estimate belief and uncertainty in each modality's predictions.
- Developing a novel fusion strategy that integrates modality-specific belief and uncertainty for improved classification reliability.
Main Results:
- The proposed framework successfully aligns heterogeneous multimodal features into a consistent distribution, reducing interference.
- The Dirichlet distribution mechanism provides interpretability by quantifying prediction belief and uncertainty for each modality.
- The novel fusion strategy effectively integrates diverse data sources, leading to enhanced classification reliability and performance.
- Promising results were achieved on the ADNI and AIBL datasets across four AD-related classification tasks.
Conclusions:
- The developed framework effectively addresses multimodal heterogeneity and reliability issues in Alzheimer's disease classification.
- The approach demonstrates significant potential for improving diagnostic accuracy and robustness in AD detection.
- This method offers a reliable strategy for multimodal data fusion in neurodegenerative disease research.
Related Concept Videos
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
801
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
801
Dementia
508
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
508
Seizures: Classification
1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Classification of Illness
8.5K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
8.5K

